As of June 2026, 1 paid clinical trial is recruiting for Gynecologic oncology in Pontiac, Michigan. Gynecologic oncology studies test PARP inhibitors, antibody-drug conjugates, maintenance therapies, and immune checkpoint inhibitors for ovarian, endometrial, cervical, and other gyn cancers. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Pontiac has approximately 93 recruiting research studies across a wide range of therapeutic areas. Michigan hosts University of Michigan Health, Henry Ford Health, and Corewell Health, running trials across oncology, neurology, and cardiology with a strong focus on precision medicine.
Researchers run research studies in Pontiac, MI at 12 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Trinity Health Saint Joseph Mercy Oakland Hospital | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 78 |
| Michigan Healthcare Professionals Pontiac | Stage IIIB Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma, Anatomic Stage I Breast Cancer AJCC v8 | 40 |
| Newland Medical Associates-Pontiac | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | 36 |
| Hope Cancer Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | 34 |
| 21st Century Oncology-Pontiac | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Castration Levels of Testosterone | 4 |
| Elixia Health - Michigan Kidney Consultants, LLC - Elixia - PPDS | Immunoglobulin A Nephropathy (IgAN), Primary Membranous Nephropathy, Type II Diabetes Mellitus | 3 |
| Saint Joseph Mercy Oakland | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Elevated CA15-3 or CEA or CA27-29 | 3 |
| Trinity Health Oakland Hospital | Acute Myocardial Infarction (AMI), Advanced Solid Tumors, Cardiovascular Risk | 2 |
| Elixia MKC | Kidney Disease | 1 |
| Elixia Michigan Kidney Consultants | Diabetic Kidney Disease (DKD) | 1 |
| Investigator Site #10 | Focal Segmental Glomerulosclerosis | 1 |
| Michigan Kidney Consultants, PC | Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease in Patients With ESKD, End Stage Kidney Disease | 1 |
Recruiting trials in Pontiac grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Michigan are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Michigan research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Pontiac from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 93 recruiting clinical trials in Pontiac, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Pontiac compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Pontiac include Acute Myeloid Leukemia (6), Stage IV Lung Cancer AJCC v8 (5), Anatomic Stage II Breast Cancer AJCC v8 (4), Lung Non-Small Cell Carcinoma (4), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Pontiac on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Pontiac include Trinity Health Saint Joseph Mercy Oakland Hospital, Michigan Healthcare Professionals Pontiac, Newland Medical Associates-Pontiac, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Pontiac are Cancer & tumors (75), Mental health & behavior (1), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.